Cargando…
Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1
Normal Schwann cells (SCs) are quiescent in adult nerves, when ATP is released from the nerve in an activity dependent manner. We find that suppressing nerve activity in adult nerves causes SC to enter the cell cycle. In vitro, ATP activates the SC G-protein coupled receptor (GPCR) P2Y2. Downstream...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251093/ https://www.ncbi.nlm.nih.gov/pubmed/30470263 http://dx.doi.org/10.1186/s40478-018-0635-9 |
_version_ | 1783373044355432448 |
---|---|
author | Coover, Robert A. Healy, Tabitha E. Guo, Li Chaney, Katherine E. Hennigan, Robert F. Thomson, Craig S. Aschbacher-Smith, Lindsey E. Jankowski, Michael P. Ratner, Nancy |
author_facet | Coover, Robert A. Healy, Tabitha E. Guo, Li Chaney, Katherine E. Hennigan, Robert F. Thomson, Craig S. Aschbacher-Smith, Lindsey E. Jankowski, Michael P. Ratner, Nancy |
author_sort | Coover, Robert A. |
collection | PubMed |
description | Normal Schwann cells (SCs) are quiescent in adult nerves, when ATP is released from the nerve in an activity dependent manner. We find that suppressing nerve activity in adult nerves causes SC to enter the cell cycle. In vitro, ATP activates the SC G-protein coupled receptor (GPCR) P2Y2. Downstream of P2Y2, β-arrestin-mediated signaling results in PP2-mediated de-phosphorylation of AKT, and PP2 activity is required for SC growth suppression. NF1 deficient SC show reduced growth suppression by ATP, and are resistant to the effects of β-arrestin-mediated signaling, including PP2-mediated de-phosphorylation of AKT. In patients with the disorder Neurofibromatosis type 1, NF1 mutant SCs proliferate and form SC tumors called neurofibromas. Elevating ATP levels in vivo reduced neurofibroma cell proliferation. Thus, the low proliferation characteristic of differentiated adult peripheral nerve may require ongoing, nerve activity-dependent, ATP. Additionally, we identify a mechanism through which NF1 SCs may evade growth suppression in nerve tumors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-018-0635-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6251093 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62510932018-11-26 Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1 Coover, Robert A. Healy, Tabitha E. Guo, Li Chaney, Katherine E. Hennigan, Robert F. Thomson, Craig S. Aschbacher-Smith, Lindsey E. Jankowski, Michael P. Ratner, Nancy Acta Neuropathol Commun Research Normal Schwann cells (SCs) are quiescent in adult nerves, when ATP is released from the nerve in an activity dependent manner. We find that suppressing nerve activity in adult nerves causes SC to enter the cell cycle. In vitro, ATP activates the SC G-protein coupled receptor (GPCR) P2Y2. Downstream of P2Y2, β-arrestin-mediated signaling results in PP2-mediated de-phosphorylation of AKT, and PP2 activity is required for SC growth suppression. NF1 deficient SC show reduced growth suppression by ATP, and are resistant to the effects of β-arrestin-mediated signaling, including PP2-mediated de-phosphorylation of AKT. In patients with the disorder Neurofibromatosis type 1, NF1 mutant SCs proliferate and form SC tumors called neurofibromas. Elevating ATP levels in vivo reduced neurofibroma cell proliferation. Thus, the low proliferation characteristic of differentiated adult peripheral nerve may require ongoing, nerve activity-dependent, ATP. Additionally, we identify a mechanism through which NF1 SCs may evade growth suppression in nerve tumors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-018-0635-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-11-23 /pmc/articles/PMC6251093/ /pubmed/30470263 http://dx.doi.org/10.1186/s40478-018-0635-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Coover, Robert A. Healy, Tabitha E. Guo, Li Chaney, Katherine E. Hennigan, Robert F. Thomson, Craig S. Aschbacher-Smith, Lindsey E. Jankowski, Michael P. Ratner, Nancy Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1 |
title | Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1 |
title_full | Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1 |
title_fullStr | Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1 |
title_full_unstemmed | Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1 |
title_short | Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1 |
title_sort | tonic atp-mediated growth suppression in peripheral nerve glia requires arrestin-pp2 and is evaded in nf1 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251093/ https://www.ncbi.nlm.nih.gov/pubmed/30470263 http://dx.doi.org/10.1186/s40478-018-0635-9 |
work_keys_str_mv | AT cooverroberta tonicatpmediatedgrowthsuppressioninperipheralnervegliarequiresarrestinpp2andisevadedinnf1 AT healytabithae tonicatpmediatedgrowthsuppressioninperipheralnervegliarequiresarrestinpp2andisevadedinnf1 AT guoli tonicatpmediatedgrowthsuppressioninperipheralnervegliarequiresarrestinpp2andisevadedinnf1 AT chaneykatherinee tonicatpmediatedgrowthsuppressioninperipheralnervegliarequiresarrestinpp2andisevadedinnf1 AT henniganrobertf tonicatpmediatedgrowthsuppressioninperipheralnervegliarequiresarrestinpp2andisevadedinnf1 AT thomsoncraigs tonicatpmediatedgrowthsuppressioninperipheralnervegliarequiresarrestinpp2andisevadedinnf1 AT aschbachersmithlindseye tonicatpmediatedgrowthsuppressioninperipheralnervegliarequiresarrestinpp2andisevadedinnf1 AT jankowskimichaelp tonicatpmediatedgrowthsuppressioninperipheralnervegliarequiresarrestinpp2andisevadedinnf1 AT ratnernancy tonicatpmediatedgrowthsuppressioninperipheralnervegliarequiresarrestinpp2andisevadedinnf1 |